Showing results (251-260 of 477) with videos related to

Sort By:
Pageof 48
American Heart Journal|March 29, 2008
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trialPatricia J M Best, Steven R Steinhubl, Peter B Berger, et al.
Heart Asia|June 22, 2016
Predictive value of high sensitivity C-reactive protein in the diagnosis and outcomes of acute aortic syndromesSoufian T AlMahameed, Gian M Novaro, Craig R Asher, et al.
The Canadian Journal of Cardiology|April 5, 2003
Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromesFadi H Khadour, Yuling Fu, Wei-Ching Chang, et al.
JAMA|November 13, 2004
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trialSteven E Nissen, E Murat Tuzcu, Peter Libby, et al.
The American Journal of Cardiology|July 28, 2004
Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary interventionDeepak P Vivekananthan, Deepak L Bhatt, Derek P Chew, et al.
American Heart Journal|January 6, 2005
Impact of female sex on outcome after percutaneous coronary interventionJohn H Chiu, Deepak L Bhatt, Khaled M Ziada, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 2005
Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injuryKai Wang, Xiaorong Zhou, Zhongmin Zhou, et al.
European Heart Journal|October 11, 2005
Direct thrombin inhibitors in acute coronary syndromes: effect in patients undergoing early percutaneous coronary interventionPeter R Sinnaeve, John Simes, Salim Yusuf, et al.
The American Journal of Cardiology|March 11, 2005
Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical centerHitinder S Gurm, Vivek Rajagopal, Robert Fathi, et al.
The American Journal of Cardiology|March 11, 2005
Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stentingAlbert W Chan, Jay S Yadav, Deepak L Bhatt, et al.
Pageof 48